Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Precision Drilling
PDS
Hutchmed (China)
HCM
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -28.12%78.02M | -28.12%78.02M | 40.33%118.63M | 6.25%101.01M | 18.94%117.36M | 20.83%108.54M | 20.83%108.54M | 2.73%84.54M | 16.36%95.07M | 20.00%98.67M |
-Cash and cash equivalents | -56.49%29.63M | -56.49%29.63M | 22.98%63.26M | -8.87%40.31M | 6.71%70.78M | 20.84%68.1M | 20.84%68.1M | -1.33%51.44M | 2.35%44.24M | 48.99%66.33M |
-Short-term investments | 19.65%48.39M | 19.65%48.39M | 67.29%55.36M | 19.41%60.7M | 44.03%46.58M | 20.81%40.45M | 20.81%40.45M | 9.75%33.1M | 32.10%50.83M | -14.23%32.34M |
Receivables | 40.26%67.48M | 40.26%67.48M | 36.46%31.85M | 34.56%20.67M | 116.29%25.06M | 33.27%48.11M | 33.27%48.11M | 20.84%23.34M | 7.99%15.36M | -57.82%11.58M |
-Accounts receivable | 36.49%64.07M | 36.49%64.07M | 36.46%31.85M | 34.56%20.67M | 116.29%25.06M | 37.80%46.94M | 37.80%46.94M | 26.68%23.34M | 10.30%15.36M | -56.57%11.58M |
-Accrued interest receivable | 9.64%637K | 9.64%637K | ---- | ---- | ---- | 82.13%581K | 82.13%581K | ---- | ---- | ---- |
-Other receivables | 368.92%2.78M | 368.92%2.78M | ---- | ---- | ---- | -65.58%592K | -65.58%592K | ---- | ---- | ---- |
Inventory | -4.75%24.91M | -4.75%24.91M | -1.25%33.46M | -7.31%33.66M | -4.37%31.67M | -7.82%26.15M | -7.82%26.15M | 5.46%33.89M | 28.62%36.32M | 41.04%33.12M |
Prepaid assets | 206.16%1.49M | 206.16%1.49M | ---- | ---- | ---- | -62.77%487K | -62.77%487K | ---- | ---- | ---- |
Other current assets | -19.33%1.76M | -19.33%1.76M | 32.65%5.98M | 4.12%3.69M | -6.15%4.29M | -3.36%2.18M | -3.36%2.18M | 32.32%4.51M | 18.13%3.54M | 47.29%4.57M |
Total current assets | -6.37%173.66M | -6.37%173.66M | 29.84%189.91M | 5.81%159.03M | 20.57%178.37M | 17.49%185.47M | 17.49%185.47M | 5.06%146.27M | 16.44%150.29M | 6.45%147.94M |
Non current assets | ||||||||||
Net PPE | -16.74%25.12M | -16.74%25.12M | -13.50%26.5M | -12.15%27.85M | -10.76%28.93M | -7.73%30.17M | -7.73%30.17M | -4.95%30.64M | -3.53%31.7M | -5.25%32.42M |
-Gross PPE | -5.04%64.21M | -5.04%64.21M | -13.50%26.5M | -12.15%27.85M | -10.76%28.93M | 1.47%67.62M | 1.47%67.62M | -4.95%30.64M | -3.53%31.7M | -5.25%32.42M |
-Accumulated depreciation | -4.39%-39.09M | -4.39%-39.09M | ---- | ---- | ---- | -10.33%-37.45M | -10.33%-37.45M | ---- | ---- | ---- |
Goodwill and other intangible assets | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | -0.23%12.79M | -0.25%12.79M | -0.27%12.79M |
-Goodwill | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M | 0.00%12.79M |
Investments and advances | 57.84%21.83M | 57.84%21.83M | -0.50%21.29M | 1,398.06%37.02M | 302.02%12.14M | 352.32%13.83M | 352.32%13.83M | 400.91%21.39M | -48.62%2.47M | -78.94%3.02M |
Non current deferred assets | -12.79%9M | -12.79%9M | -1.38%11.03M | -1.98%11.44M | 2.08%11.65M | 0.59%10.32M | 0.59%10.32M | -0.28%11.18M | 1.07%11.67M | 3.12%11.42M |
Other non current assets | 0.77%391K | 0.77%391K | 205.43%1.18M | 22.05%919K | 0.52%387K | 6.01%388K | 6.01%388K | 6.03%387K | 106.30%753K | 5.48%385K |
Total non current assets | 2.42%69.14M | 2.42%69.14M | -4.72%72.79M | 51.58%90.01M | 9.78%65.89M | 14.08%67.5M | 14.08%67.5M | 25.43%76.39M | -4.83%59.38M | -17.55%60.03M |
Total assets | -4.02%242.79M | -4.02%242.79M | 17.98%262.71M | 18.78%249.04M | 17.45%244.27M | 16.56%252.97M | 16.56%252.97M | 11.26%222.66M | 9.50%209.67M | -1.80%207.97M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -0.52%4.06M | -0.52%4.06M | 88.72%3.41M | 175.01%4.79M | 133.54%4.58M | 276.80%4.08M | 276.80%4.08M | -6.32%1.81M | -35.90%1.74M | -55.07%1.96M |
-accounts payable | 3.63%3.11M | 3.63%3.11M | 88.72%3.41M | 173.00%4.75M | 78.25%3.49M | 268.55%3M | 268.55%3M | -6.32%1.81M | -35.90%1.74M | -55.07%1.96M |
-Total tax payable | -12.07%947K | -12.07%947K | ---- | --35K | --1.08M | 301.87%1.08M | 301.87%1.08M | ---- | ---- | ---- |
Current accrued expenses | 16.67%15.69M | 16.67%15.69M | -8.77%9.54M | -12.73%9.16M | -23.40%6.27M | -0.06%13.45M | -0.06%13.45M | 0.47%10.46M | 22.19%10.49M | 14.01%8.19M |
Current provisions | 3.12%1.09M | 3.12%1.09M | 4.13%983K | --962K | --989K | 9.19%1.06M | 9.19%1.06M | 3.74%944K | ---- | ---- |
Current debt and capital lease obligation | 12.79%2.02M | 12.79%2.02M | 12.87%1.96M | 13.03%1.91M | 12.71%1.85M | 11.94%1.79M | 11.94%1.79M | 12.11%1.74M | 12.23%1.69M | 12.75%1.65M |
-Current capital lease obligation | 12.79%2.02M | 12.79%2.02M | 12.87%1.96M | 13.03%1.91M | 12.71%1.85M | 11.94%1.79M | 11.94%1.79M | 12.11%1.74M | 12.23%1.69M | 12.75%1.65M |
Current deferred liabilities | -47.95%571K | -47.95%571K | 102.39%2.97M | 153.47%3.21M | 137.70%3.45M | -8.20%1.1M | -8.20%1.1M | -31.99%1.47M | -15.86%1.27M | -29.46%1.45M |
Current liabilities | 9.11%23.43M | 9.11%23.43M | 14.94%18.87M | 31.87%20.03M | 29.43%17.14M | 17.32%21.47M | 17.32%21.47M | -3.19%16.42M | -0.14%15.19M | -17.09%13.24M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -19.07%9.3M | -19.07%9.3M | -17.77%9.86M | -16.60%10.42M | -15.51%10.96M | -13.48%11.49M | -13.48%11.49M | -12.67%11.99M | -11.91%12.49M | -11.26%12.97M |
-Long term capital lease obligation | -19.07%9.3M | -19.07%9.3M | -17.77%9.86M | -16.60%10.42M | -15.51%10.96M | -13.48%11.49M | -13.48%11.49M | -12.67%11.99M | -11.91%12.49M | -11.26%12.97M |
Other non current liabilities | -72.46%57K | -72.46%57K | -54.95%100K | -60.00%86K | -48.03%132K | 71.07%207K | 71.07%207K | 74.80%222K | -5.29%215K | 12.39%254K |
Total non current liabilities | -20.02%9.35M | -20.02%9.35M | -18.45%9.96M | -17.33%10.5M | -16.13%11.09M | -12.72%11.7M | -12.72%11.7M | -11.87%12.21M | -11.81%12.7M | -10.90%13.22M |
Total liabilities | -1.16%32.78M | -1.16%32.78M | 0.70%28.83M | 9.46%30.53M | 6.67%28.23M | 4.62%33.17M | 4.62%33.17M | -7.09%28.63M | -5.82%27.89M | -14.11%26.46M |
Shareholders'equity | ||||||||||
Share capital | 1.54%66K | 1.54%66K | 1.54%66K | 1.54%66K | 1.56%65K | 1.56%65K | 1.56%65K | 1.56%65K | 1.56%65K | 0.00%64K |
-common stock | 1.54%66K | 1.54%66K | 1.54%66K | 1.54%66K | 1.56%65K | 1.56%65K | 1.56%65K | 1.56%65K | 1.56%65K | 0.00%64K |
-Preferred stock | --0 | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Retained earnings | 27.89%105.71M | 27.89%105.71M | 30.84%82.24M | 38.66%73.75M | 35.62%74.4M | 35.16%82.66M | 35.16%82.66M | 32.52%62.85M | 24.75%53.19M | 21.91%54.86M |
Paid-in capital | 7.99%235.01M | 7.99%235.01M | 9.50%231.91M | 7.70%225.24M | 7.13%222.12M | 6.18%217.62M | 6.18%217.62M | 4.43%211.78M | 4.50%209.14M | 4.61%207.34M |
Less: Treasury stock | 62.60%130.87M | 62.60%130.87M | 0.00%80.49M | 0.00%80.49M | 0.00%80.49M | 0.00%80.49M | 0.00%80.49M | 0.00%80.49M | 0.04%80.49M | 30.05%80.49M |
Gains losses not affecting retained earnings | 322.73%98K | 322.73%98K | 181.42%149K | 51.97%-61K | 77.86%-60K | 87.39%-44K | 87.39%-44K | 64.05%-183K | 75.34%-127K | 35.17%-271K |
Total stockholders'equity | -4.46%210.01M | -4.46%210.01M | 20.54%233.87M | 20.21%218.51M | 19.03%216.04M | 18.60%219.81M | 18.60%219.81M | 14.60%194.03M | 12.31%181.78M | 0.30%181.5M |
Total equity | -4.46%210.01M | -4.46%210.01M | 20.54%233.87M | 20.21%218.51M | 19.03%216.04M | 18.60%219.81M | 18.60%219.81M | 14.60%194.03M | 12.31%181.78M | 0.30%181.5M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |